News

Archive: December, 2020

DOD Awards University of Louisville $8.5 Million for COVID-19 Q-Griffithsin Repurposing Effort
December 9, 2020 — The JPM CBRN Medical leveraged an academic partnership to study the repurposing of a compound that shows promise against COVID-19... MORE

JPM CBRN Medical Tiger Team Takes Bold Action to Support Pandemic Response
December 4, 2020 — It is difficult to remember a time when “coronavirus” was not a part of our day-to-day vocabulary. The COVID-19 pandemic emerged from the shadows and threw the world into a tailspin, demanding ingenuity and resourcefulness as it pushed worldwide healthcare systems to their limits. As nations quickly scrambled to adapt and respond to the global... MORE

DOD-Funded Drug Remdesivir Receives FDA Approval for COVID-19 Treatment
December 1, 2020 — Yesterday, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.’s Veklury® (Remdesivir) for treatment of hospitalized COVID-19 patients who are 12 years of age or older and weigh at least 40 kilograms (88 lbs). The approval of Veklury® was supported by the agency’s analysis of data from three randomized, controlled clinical... MORE

News Search

News Archive - Search by Year and Month

2025 (7)
2024 (40)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
December (3)
November (1)
August (1)
July (3)
May (1)
April (1)
March (4)
February (1)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.